Skip to main navigation
Back
revance revance
  • Contact Revance
  • Login
Menu
  • Aesthetics
    Back Aesthetics
    • Overview
    • RHA®
    • HintMD
    • Neuromodulator
    • Neuromodulator Uses
    • Clinical Highlights
  • Therapeutics
    Back Therapeutics
    • Overview
    • Cervical Dystonia
    • Upper Limb Spasticity
    • Plantar Fasciitis
    • Clinical Highlights
  • Investors
    Back Investors
    LATEST NEWS
    • Our Latest
    • December 22, 2020
    Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection All News
    • Investor Relations
    • Press Releases
    • Events & Webcasts
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Analyst Coverage
    • Investor FAQ
  • Company
    Back Company
    OUR LATEST
    • Our Latest
    • December 22, 2020
    Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection Our Latest
    • Overview
    • About Revance
    • Leadership Team
    • Board of Directors
    • Partnerships
    • Investigator Sponsored Trials
    • Corporate Social Responsibility
    • Contact Revance
  • News
  • Careers
    Back Careers
    • Overview
    • Career Opportunities
    • Culture
    • Benefits & Perks
  • facebook
  • instagram
  • twitter
  • linkedin
1222 Demonbreun St
Suite 2000
Nashville, TN 37203
+1 (510) 742-3400
  • Contact Revance
  • Login

© Copyright 2021

All Rights Reserved

Terms of Use

Privacy Policy

Breadcrumb

  • Home
  • Investors
  • Events webcasts
  • Presentations and corporate materials

Presentations and Corporate Materials

Presentations and Corporate Materials

Presentations and Corporate Materials

Investor Presentation
January 12, 2021
Phase 3 Cervical Dystonia Presentation October 2020
October 14, 2020
Video Link - Phase 3 Cervical Dystonia Presentation October 2020
October 14, 2020
Infographic 2 - Phase 3 Cervical Dystonia Presentation October 2020
October 14, 2020
Infographic 1 - Phase 3 Cervical Dystonia Presentation October 2020
October 14, 2020
Hint Report of Organizational Actions Affecting Basis of Securities Form 8937
August 6, 2020
Revance Announces TEOXANE SA Transaction
January 10, 2020
SAKURA 3 Results Presentation
December 4, 2018
SAKURA 1 and SAKURA 2 Phase 3 Topline Results
December 6, 2017
Phase 2 Cervical Dystonia 24-Week Results Presentation
May 18, 2017

Investor Relations

  • Investor Relations
  • Press Releases
  • Events & Webcasts
    • Presentations and Corporate Materials
    • Video Library
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us
image description

Revance - Shareholder Tools

  • Print Page
  • Printed Materials
  • Email Alerts
  • Download Library
  • RSS News Feeds
  • Share
  • Search

Keep up with Revance

revance
1222 Demonbreun St
Suite 2000
Nashville, TN 37203
+1 (510) 742-3400
  • facebook
  • instagram
  • twitter
  • linkedin

Aesthetics

  • Overview
  • RHA®
  • HintMD
  • Neuromodulator
  • Neuromodulator Uses
  • Clinical Highlights

Therapeutics

  • Overview
  • Cervical Dystonia
  • Upper Limb Spasticity
  • Plantar Fasciitis
  • Clinical Highlights

Investors

  • Investor Relations
  • Press Releases
  • Events & Webcasts
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQ

Company

  • Overview
  • About Revance
  • Leadership Team
  • Board of Directors
  • Partnerships
  • Investigator Sponsored Trials
  • Corporate Social Responsibility
  • Contact Revance

News

  • All News
  • In the News
  • Our Latest

Careers

  • Overview
  • Career Opportunities
  • Culture
  • Benefits & Perks
  • © Copyright 2021
  • All Rights Reserved
  • Terms of Use
  • Privacy Policy
  • Corporate Social Media Community Guidelines
Back to top
  • Facebook
  • LinkedIn